��������

Emily Radke has a diverse work experience in the scientific field. Emily began their career in 2012 as a Student Lab Assistant at Pfizer. In 2015, they took on a Biologist role at Eli Lilly and Company, as well as a PhD Candidate in Molecular Pharmacology at NYU School of Medicine, Sackler Institute of Graduate Biomedical Sciences. Her responsibilities at NYU included independently designing and implementing research proposals and experiments based on current scientific literature, as well as interpretation, analysis and presentation of results in weekly lab meetings and in yearly department-wide seminars and at international scientific conferences. In 2021, they joined Adimab as an Associate Manager, Strategic Alliances and Scientist I.

Emily Radke's education history includes a Doctor of Philosophy (Ph.D.) in Biological and Biomedical Sciences from New York University (2015-2021), a Master of Science (MS) in Biomedical Sciences, General from New York University (2015-2018), a Bachelor of Arts (BA) in Biochemistry from the University of San Diego (2011-2015), and a Master of Philosophy (MPhil) in Biomedical Sciences, General from New York University (2015-2019).